Product Information
ISOSORBIDE DINITRATE 30 MG TAB is a generic product labeled by Advagen Pharma Ltd., priced at $0.2808 per EA under NDC 72888008400. Its NADAC has been published 187 times since Mar 8, 2023.
FDA first approved this application on Jul 8, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888008400
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ISOSORBIDE DINITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA215723FDA Approved
7/8/2022
TE Code
AB
On Market Since
7/8/2022
Pharmacological Classes
Price Statistics
The NADAC for ISOSORBIDE DINITRATE 30 MG TAB has been published 187 times since Mar 8, 2023, and over the history we have for it it has declined 26.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2808 per EA |
|---|---|
| All-time high | $0.4639 (Apr 10, 2024) |
| All-time low | $0.2703 (Mar 18, 2026) |
| 52-week high | $0.3493 |
| 52-week low | $0.2703 |
| Median price | $0.3578 |
| Average price | $0.3557 |
| Largest weekly change | +30.3% (Aug 21, 2024) |
| Weeks tracked | 187 |
| Tracking since | Mar 8, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
isosorbide dinitrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitrate Vasodilator class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ISOSORBIDE DINITRATE 30 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ISOSORBIDE DINITRATE 30 MG TAB, manufactured by Advagen Pharma Ltd., is $0.2808 per EA (NDC 72888008400), effective Sep 30, 2026.
How has the price of ISOSORBIDE DINITRATE 30 MG TAB changed over time?
Over the history we have for it, the NADAC for ISOSORBIDE DINITRATE 30 MG TAB has declined 26.6%. It has been tracked across 187 weekly CMS publications since Mar 8, 2023.
What are the highest and lowest recorded NADAC prices for ISOSORBIDE DINITRATE 30 MG TAB?
Since Mar 8, 2023, the NADAC for ISOSORBIDE DINITRATE 30 MG TAB has ranged from a low of $0.2703 (Mar 18, 2026) to a high of $0.4639 (Apr 10, 2024), with a median of $0.3578 per EA.
Are there cheaper alternatives to ISOSORBIDE DINITRATE 30 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ISOSORBIDE DINITRATE 30 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures ISOSORBIDE DINITRATE 30 MG TAB?
ISOSORBIDE DINITRATE 30 MG TAB (NDC 72888008400) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.